About Ralington Pharma
Ralington Pharma is a company based in Ahmedabad (India) founded in 2015. It operates as a B2B. Ralington Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Ahmedabad, India
- SectorsHealthcare
- Email••••••••
- Website ralingtonpharma.com
- Legal Name Ralington Pharma Llp
- Date of Incorporation 01 Jun, 2015
- Jurisdiction Sanand, Gujarat, India
- Annual Revenue₹3.65 Cr
FY 2023
- Net Profit₹3 Lakh
FY 2023 · 1% margin
- EBITDA-₹2.4 Lakh
FY 2023 · -1% margin
Associated legal entities of Ralington Pharma
Ralington Pharma operates through Ralington Pharma Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ralington Pharma Llp CIN AAE-0673 | Active | 01 Jun 2015 | Sanand, Gujarat | ₹3.7 Cr | – | 2 | View details |
Board of directors of Ralington Pharma Llp (Ralington Pharma)
Ralington Pharma Llp is the primary company behind Ralington Pharma. The board of Ralington Pharma Llp currently have 2 directors; the longest-serving is Kartik Harshad Barot, appointed in 2015. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kartik Harshad Barot DIN 07183821 | Designated Partner | 01 Jun 2015 | 11 yrs 4 mo | Ralington Pharma Llp |
| Smita Kartik Barot DIN 10575683 | Designated Partner | 02 Apr 2024 | 2 yrs 6 mo | Ralington Pharma Llp |
Financials of Ralington Pharma
Figures of Ralington Pharma Llp, the primary company behind Ralington Pharma, for FY 2023. Revenue was ₹3.65 Cr. Net profit was ₹3 Lakh (1% margin). EBITDA was -₹2.4 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +77% over three years and +113% over five years.
- ₹3.65 CrRevenue · FY 2023
- ₹3 LakhNet profit · 1% margin
- -₹2.4 LakhEBITDA · -1% margin
- +77%Revenue CAGR, 3 years
- +113%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ralington Pharma Llp are on its company page.
Detailed financial statements for Ralington Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Ralington Pharma
Ralington Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Ralington Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Ralington Pharma
10 companies that operate in the same segment as Ralington Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ralington Pharma
Ralington Pharma was founded in 2015.
Ralington Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Ralington Pharma, Ralington Pharma Llp, reported revenue of ₹3.65 Cr for FY 2023.
Ralington Pharma, established in 2015, excels in healthcare and pharmaceuticals, producing pharmaceutical products, producing manufactured goods, and active ingredients. Produces high-quality active pharmaceutical ingredients and intermediates. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Ralington Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Ralington Pharma operates through Ralington Pharma Llp.
The legal entities of Ralington Pharma currently have 2 directors, including Kartik Harshad Barot, Smita Kartik Barot.